Innovative Medicines Initiative (IMI) Case Study Analysis Reveals the True Added Value of Early-Phase Public-Private Partnerships (PPPs)

Biotechnol Law Rep. 2015 Aug 1;34(4):153-165. doi: 10.1089/blr.2015.29008.hs.